About Oxford Biotherapeutics:

Oxford Biotherapeutics is a clinical-stage biotechnology company focusing on the development of antibody therapeutics for the treatment of cancer.OBTsOGAP-verify platform is the world's largest, cancer specific, membrane protein library, directly measuring plasma membrane protein expression in patienttumors. OGAP is used to identifynovel, highlytumorspecific antigens for novel first-in-class ADC, T-cell Engager (TCE)and Chimeric Antigen Receptor (CAR-T) targets. Our lead asset, OBT076, is an Antibody Drug Conjugate (ADC) in Phase 1b clinical development. Our clinical and pre-clinical pipeline of novel biologics is balanced between internal programs, focused on ADCs and checkpoint regulators, and externally partnered programs with key innovators in oncology such asRoche,GSKand Zymeworks.

Job Description

We areseekinga highly motivated and intellectually curiou...